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Objective: The incidence of lung cancer is four times higher in people with chronic
obstructive pulmonary disease (COPD) compared with the general population.
Promotion of a shorter time from symptom onset to presentation is one potential
strategy for earlier lung cancer diagnosis, but distinguishing respiratory symptoms
can be difficult. We investigated how the experience of COPD influences symptom
appraisal and help seeking for potential lung cancer symptoms.
Methods: We conducted qualitative interviews with men (n = 17) and women
(n = 23) aged 40 to 83 years with COPD. Topic guides drew on the integrated
symptom‐response framework and covered symptom experience, interpretation,
action, recognition, help seeking, evaluation, and reevaluation. We used the frame-
work method to analyse the data.
Results: Participants said that they attributed chest symptoms to their COPD; no
other cause was considered. Participants said that family/friends noticed changes in
their symptoms and encouraged help seeking. Others felt isolated by their COPD
because they could not get out, were fatigued, or were embarrassed. Participants
visited health professionals frequently, but increased risk of lung cancer was not
discussed.
Conclusions: Our study provides insight into different levels of influence on
symptom appraisal and targets for intervention. Greater awareness of increased lung
cancer risk and support to act on symptom changes is essential and could be achieved
through a concerted information campaign. Health professionals working with people
with COPD could also optimise appointments to support symptom appraisal of
potential lung cancer symptoms.- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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Lung cancer is one of the most common cancers in the United
Kingdom, with more than 35 000 deaths each year.1 Most lung
cancers are detected at a late stage when prognosis is poor, and only
10% of people diagnosed with lung cancer will survive for 5 years.1 To
increase lung cancer survival, improvements in the lung cancer care
pathway are needed. But first, we need to know where and how to
intervene for most benefit.
People diagnosed with lung cancer often have multiple symptoms,
which make it hard for patients and health care professionals to act
promptly in relation to help seeking or onward referral.2,3 The pres-
ence of chronic obstructive pulmonary disease (COPD), which has
similar symptoms, makes deciding to act even more difficult.4,5 The
similarity in symptoms is of particular concern because people with
COPD are four times more likely to develop lung cancer than the
general population.6 One of the problems might be that people with
COPD do not know that COPD poses an increased risk of lung cancer,
which is independent from the risk posed by smoking, or that health
professionals do not know it or consider it salient in consultations.7,8
People with COPD will experience ongoing lung symptoms, and
attributing any changes in symptoms or new symptoms to a cause
other than their existing diagnosis of COPD may be challenging. In a
previous study, a history of COPD was one of the few factors
independently associated with increased time before seeking initial
contact with a health care professional,9 and qualitative research with
people experiencing symptoms suggestive of lung cancer confirmed
that symptom appraisal was made difficult by lung comorbidities
masking new respiratory changes.10-12
The common sense model13 describes the self‐regulation of
health and illness with the goal being able to manage or regulate the
perceived threat. More recently, an integrated symptom‐response
framework (ISRF)14 has been proposed (Figure S1) that provides a
cross‐disciplinary model of symptom appraisal, where responses to
symptoms are considered an iterative process influenced by the self,
social interaction, cultural expectations, and social structure. Emphasis
is on the changeable and cyclical nature of symptom appraisal, which
is particularly important for COPD, where changes in existing respira-
tory symptoms may be a critical cue to action.
The impact of comorbidities on cancer diagnosis more generally
has received little attention, and there is a lack of theoretical underpin-
ning to inform our understanding.15 Furthermore, previous work
considering responses to potential symptoms of lung cancer has
examined symptom appraisal post cancer diagnosis11 or post referral12
but has not attempted to capture the symptom appraisal and help‐
seeking process in an everyday context of people living with COPD.
We used the ISRF to explore how people with COPD appraise and
respond to potential lung cancer symptoms.2 | METHODS
2.1 | Design
We conducted a qualitative study involving semistructured interviews
with men and women with COPD in Glasgow, Scotland, UK, between
July 2016 and May 2017 (Data S1).2.2 | Participants and procedure
Glasgow provided an ideal setting for the study because rates of lung
cancer in Scotland are among the highest in the world. We recruited
people diagnosed with COPD aged 40 years or older using a specialist
qualitative research company. From their database of people inter-
ested in research, we sought a sample of participants who had COPD,
with approximately equal numbers of men and women and people
living in areas of high and low deprivation. The research company
contacted potential participants with written information about the
study. If the person was interested, they arranged an interview with
the researcher (Y.C.). Written consent was obtained from each
participant. Ethical approval was received from the University of
Glasgow, College of Medical, Veterinary & Life Sciences (200150084).
We finished interviewing participants when we reached data
saturation, using a stopping criterion of three interviews after new
ideas stopped emerging.16 In total, 17 men and 23 women were
interviewed, ranging in age from 40 to 87 years (Table S1).2.3 | Topic guide
We developed a topic guide to explore interviewees' experience of
lung symptoms over the previous 6 to 12 months (Data S2). The aim
of the guide was to capture the symptom appraisal process in an
everyday context. The interview began with the open question, “In
the last six to twelve months, have you experienced any new or chang-
ing health symptoms?” Only four participants had not experienced any
new or changing symptoms in the past 6 to 12 months, and these
people answered the question by going back further to describe their
experience. The interview continued with semistructured questions
drawing on the ISRF,14 including questions on symptom experience,
interpretation, and action. The draft topic guide was reviewed by all
authors and discussed at a multidisciplinary advisory group meeting,
including a patient representative. Following the initial batch of 10
interviews, it was striking that interviewees did not mention cancer;
therefore, the topic guide was adjusted to include a fuller discussion
of lung cancer at the end of the interview.
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Interviews were digitally recorded, transcribed verbatim, and imported
into the software package NVivo, version 11 (QSR International,
Melbourne, VIC, Australia). We analysed the data using the framework
method,17 which allows organisation of data according to key themes
and concepts. Following familiarisation with the transcripts by Y.C.,
K.A.R., and K.L.W., an initial thematic coding frame was developed
and then discussed among the wider research team. The themes were
based on the ISRF as per the topic guide. There was little evidence of
additional themes relating to symptom response emerging. The agreed
themes were applied to extract data from the transcripts for further
interpretation. We arranged the framework matrix in a spreadsheet
containing one data‐generated theme per worksheet with subthemes
in the columns. The rows represented individual participants. Y.C.
populated the framework matrix with relevant data extracts from
the transcripts and summarised each theme with representative
extracts. K.A.R. and K.L.W. reviewed the summaries and discussed
them with Y.C. to check consistency with the data. Data requests
should be addressed to the corresponding author.3 | RESULTS
Participants were interviewed in their own homes, apart from two
who requested to be interviewed in cafes. Interviews lasted anaverage of 42 minutes (range: 24‐72 min). The analysis was organised
into four main “circles of influence” on the response to symptoms (self,
social interaction, culture, and social structure; Figure 1). Each
influence is described with supporting quotes from participants, along
with their participant number, gender, and age.
3.1 | Influence—self
Knowledge of COPD and their own body were prominent in
participants' accounts. Participants described having always had “chest
problems”; eg, they had suffered from asthma since childhood and
then later developed COPD. Participants emphasised that their long
history of COPD meant that they had come to know their own bodies
and felt they had the expertise and confidence to advise their doctors
on appropriate treatment. One participant described how she had
educated herself about her condition.I think I know all about my lungs now. I think. I am quite
educated …. when I took the pneumonia there was
different names used, and I wasn't sure what they
meant. And, I looked that up. [P6, female, age 64]Participants said that because they knew their body so well, they
were able to make sound judgements about help seeking.Actually, but I think your body's the best doctor, you
know? Tells you everything. [P4, male, age 78]FIGURE 1 Thematic structure according to
the integrated symptom‐response
framework14
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chest symptoms, participants tended to draw on external factors such
as smoking, the weather, or age:It's always worse most winters, because we are going into
the damp cold weather. That's when I am worse. In the
summer time it's more like, it's reverting to my asthma,
you know, allergies to the pollen and things like that.
[P12, male, age 52]Participants always drew on their experience of COPD when
attributing symptoms beyond external factors such as the weather
or illness. It did not seem to occur to them that a change in symptoms
could have a cause other than COPD.I just thought it was down to the COPD. Yeah, I did not
think it was anything else really, just, I just thought it
was, I know it's a progressive illness. So I thought well
it's getting a bit worse. [P14, female, age 67]Participants were unaware that people with COPD are at
increased risk of developing lung cancer and attributed worsening
symptoms to their COPD. Many expressed surprise when the
researcher informed them of this near the end of the interview.No, I never gave cancer a thought I was just thinking of
the breathing I never actually, … … you are saying to
yourself, well, if this gets really worse, like what I am
saying, you just keep putting it down to that [COPD].
[P33, female, age 61]3.2 | Influence—social interaction
The role of other people was central; family members could draw
attention to bodily changes, such as noticing a worsening cough or
changed pallor:Or if I am getting up in the morning and going to work or
something like that, if my mum's round, she'll be like,
“Think you need to put a bit more blusher on,” you
know? She can see it. She can see that colour draining
from me. [P9, female, age 45]Participants also provided examples of other people noticing
symptoms before they did.They would notice the wheeziness when I am sitting
down. Short of breath when I am sitting down as well.
That's what they would notice and they would notice
the wheeziness and just probably the way I look, kind of
grey. [P32, female, age 53]Participants talked about family members encouraging them to
seek help for a changing or worsening symptom. Participants
described how family members would even go so far as to arrange
appointments or drive them to the hospital:They come up and they say, no, we are not waiting. Telly
goes off, bag ready. “you are going to the hospital.” [P3,
female, age 69]COPD participants also talked about how the condition was
socially isolating and reduced their opportunity for social interaction
because of the physical limitations of the illness:I do not have much of a social life now … …. So I have sort
of socially excluded myself from a lot of things. Because I
cannot keep, I cannot really keep up with any of it, you
know, any walking or anything like that now, you know.
[P25, male, age 68]Participants described deliberately avoiding social situations
where symptoms would become apparent because they perceived
them to be embarrassing or did not want people to notice them:I hate staying with anybody, because, the noise of my
chest, and coughing on, and—maybe—we went away,
crowd of women …. And it was one woman, and she
went, “Oh, I could not sleep with you.” Oh, I felt awful—
I cried my eyes out. [P3, female, age 69]This resulted in participants describing that they had fewer people
in their lives, which may also impact on help seeking:I think at one time I was sociable and now there is
virtually nobody in my life so. [P12, male, age 52]3.3 | Influence—culture
In talking about how they respond to changing or new chest
symptoms, participants portrayed the role of being a “good patient”:Yes, mm. “Persistent three weeks on with chest
infection”—well, obviously I would go to the doctor's
immediately. “A cough that does not …” Go to the
doctor's immediately. [P1, female, age 74]Another feature of culturally acceptable responses was to appear
stoical in response to symptoms. Participants were keen to be seen to
“not make a fuss” or as time‐wasters.I do not know, it's just a thing I do. I am not one for
running to the doctor, to be honest with you. [P17,
male, age 58]Participants also emphasised that poor health was something that
had to be accepted.I mean, look at—you have just got to accept that that's
the way it is. … Yeah. [P1, female, age 74]In more extreme cases, this view led to a fatalistic attitude, as it
did with one participant, who was weary of “putting up with” his poor
health:
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granddaughter grow up but really I have had enough.
[P12, male, age 52]The role of smoking also influenced how participants responded
to symptoms. Participants acknowledged that smoking is an increas-
ingly culturally unacceptable behaviour, particularly for people with
COPD. In some instances, the stigma associated with continued
smoking made participants reluctant to seek help because they felt
the doctor would blame smoking for their symptoms:… … they'll just tell me it was the fags [cigarettes]. Do you
know what I mean? [P2, male, age 60]3.4 | Influence—social structure
Our participants described the influence of social structure on
potential responses to new or changing symptoms and help‐seeking
behaviour. Participants talked about barriers to accessing care, which
included scheduling appointments outside of usual working hours
and difficulties in obtaining an appointment.Well the only thing I could do is you know go and see the
doctor, see what he thinks. As I say, I know they are
under a lot of pressure, but I think you know, it's easier
to get in and see the pope than it is to see our doctor.
[P13, male, age 76]Barriers to accessing care and health services also included
the physical challenge of travelling to the health centre, which is
particularly relevant for COPD patients who may have reduced
mobility.Because I cannot get a bus from here down to my
doctors. I can get two buses but the problem with that
is it runs every half hour and the two of them run at
the same time. [P21, female, age 54]While difficulties in accessing care were talked about among our
participants, they also described that they had better access to health
services because of their COPD diagnosis. Doctors acknowledged
the seriousness of their symptoms and accommodated them with
emergency appointments or prescriptions.I have got what they call “save” antibiotics in the house.
And that's good because that takes away some of the
worry. [P36, female, age 65]4 | CONCLUSIONS
This study considered how the experience of COPD influences
symptom appraisal and help seeking for potential lung cancer
symptoms. Drawing on the ISRF,14 our analysis identified key influ-
ences across many levels, including self, social interaction, culture,and social structure. A common thread was that having an existing
explanatory model impacted not only on how participants interpreted
and responded to symptoms but also in how social interactions and
structures, described within the ISRF, responded in the presence of
this existing morbidity. This made it difficult for patients and health
care professionals to consider the possibility of lung cancer in
response to a new or changing lung symptom, despite people with
COPD being at higher risk of lung cancer.
Participants in the current study did not identify any potential link
between their symptoms and lung cancer, nor recognise that they
were at higher risk, even after specific probing by the interviewer. This
is consistent with previous research, which reported that public
awareness of COPD as a lung cancer risk factor, independent of
cigarette smoking, is low.8 COPD participants attributed new or
ongoing respiratory changes to their existing condition or at most
considered their symptoms to be exacerbated because of other
external factors such as the weather. There was no evidence that
social interactions with friends or family or health care professionals
themselves discussed alternative explanations (eg, the possibility of
cancer), and therefore, their existing explanatory model remained
unchallenged.18
The ready attribution of new symptoms to innocuous explana-
tions but not to the presence of a new, frightening illness such as lung
cancer could be due to what Anderson et al19 called “optimistic bias,”
the tendency to favour nonthreatening explanations to those that are
threatening. Although participants appeared to look for innocuous
explanations, friends and family could trigger help seeking in particular
by highlighting visible symptoms. The importance of interpersonal
relationships in help seeking has been observed before20,21 and
specifically in the context of lung cancer.11
Moving beyond social interaction to wider cultural influences,
we identified a concern among COPD participants about being
labelled a “time‐waster” and valued cultural attributes of stoicism.
Worry about wasting the doctor's time is a well‐recognised barrier
to prompt help seeking11,22,23 and demonstrates the complex and
delicate moral balance patients have to make between responsible
use of health care services and not taking unnecessary risks with
their health.
Despite having a recognised chronic condition requiring medical
involvement, participants were keen to distance themselves from
those considered time‐wasters and instead stressed that they would
consult their doctor only when absolutely necessary. Stoicism and
acceptance of poor health also manifested as fatalism, with one man
(aged 55 years) saying wearily “I've lived my life.” Fatalism has previ-
ously been identified as a barrier to medical help seeking,24 and this
is important because raising awareness of a link between COPD and
cancer may be detrimental if it leads to increased fatalism. Raising
awareness of the link between COPD and lung cancer should
therefore be conducted alongside raising awareness of the benefits
of early diagnosis.
According to the ISRF,14 social structure can influence responses
to symptoms directly (eg, through health care access) or indirectly
(though social networks' access to resources, knowledge, and so on).
BOX 1 Recommendations
Finding Recommendations
Cancer was not considered a
potential explanation for
chest symptoms.
•Alert people with COPD to
risk of lung cancer.
•Alert people with COPD to
consult with changes in
symptoms.
•Encourage relevant charities/
support groups to include
information about lung
cancer risk in
communications.
Family or friends noticed
changes in symptoms and
encourage help seeking.
•Provide information aimed at
empowering patients and
family members to speak
about symptoms and take
action.
•Encourage family members to
attend consultations.
People felt isolated by their
COPD.
•Encourage patient
engagement with COPD
services such as pulmonary
rehabilitation programmes
or other well‐being/exercise
classes to gain social
support from others with
COPD.
Participants visited health
professionals frequently, but
lung cancer risk was not
•Alert health professionals to
be vigilant to lung cancer
risk in COPD patients.
CUNNINGHAM ET AL. 723We observed evidence for both. Firstly, there was a juxtaposition
between commonly identified access barriers to help seeking,
alongside expedited access due to having COPD. Different dimen-
sions of accessing health care were highlighted, including lack of
availability and problems with accessibility.25 Conversely, participants
described expedited access or “short‐cuts” to accessing medical care
because of their condition. Although this may appear helpful on one
level, it may also result in health care professionals attributing new
or changing symptoms to existing medical conditions rather than con-
sidering alternative explanations.
Social isolation also impacted on help seeking—COPD participants
described lack of mobility and the need to hide embarrassing or
worsening symptoms. Evidence of social isolation in COPD patients
has been identified before,26 but our study highlights that this may
have wider consequences on consulting behaviour.
A major strength of this study is that it is the first to examine
the process of symptom appraisal of potential warning signs for
cancer in patients with an existing health condition prior to the
potentially biasing effects of cancer diagnosis or referral on suspicion
of cancer. The study adopted a theoretically driven approach to
capture the symptom appraisal process in an everyday context for
a diverse sample of men and women of relatively low socioeconomic
status.
discussed. •Move away from a “disease
silo” approach. Consultations
could include the question
from the health professional,
“is there anything else?” This
recommendation is
transferable to other patient
groups with pre‐existing
conditions at risk of
developing cancer.
COPD, chronic obstructive pulmonary disease.4.1 | Study limitations
Glasgow was purposively identified as a good site for the study
because of high prevalence of COPD and lung cancer; however, we
acknowledge that our sample is geographically limited. We used a
specialist qualitative research company for recruitment that may have
biased our sample because these people are interested in taking part
in research. However, on the basis of informal feedback from partici-
pants, it is our belief that this form of recruitment allowed us to reach
participants who would not have engaged with more conventional
approaches.4.2 | Clinical implications
Our study provides insights into how to intervene at different levels
of influence to improve the likelihood of patients and health care
professionals suspecting and acting on potential lung cancer. Studies
testing health care–based interventions addressing symptom
awareness/normalisation and fatalism in patients at high risk of lung
cancer are ongoing.27,28 Our study highlights the potential need for
similar interventions in patients with COPD, and we have developed
recommendations in order to help mitigate specific issues within this
sample (see Box 1). For example, raising the awareness of the link
between cancer and COPD in patients will help in identifying
symptoms as something different, but this needs to be dealt with
sensitively to avoid increased fatalism. For those who are socially
isolated, encouraging engagement with COPD services, such as
pulmonary rehabilitation programmes, may provide social support, inaddition to providing another opportunity to engage with symptom
awareness messages.
Emerging evidence suggests that doctors may be reluctant to
openly discuss cancer with their patients.29 Another avenue may
therefore be to help doctors recognise symptoms as a presentation
of possible cancer and encourage open and honest conversations
between patients and doctors about the link between COPD
and cancer.
The present study advances our knowledge of the process of
symptom appraisal among people with an existing chronic health
condition by highlighting the influence of individual, social, and
cultural factors and how these may culminate in a later diagnosis of
lung cancer. We make a number of recommendations to optimise
lung symptom appraisal and prompt help seeking for people with
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